Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A SOTO

Showing results (881-890 of 968) with videos related to

Pageof 97
Sort By:
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Journal of Neurochemistry|July 22, 2025
Dissection of Neurochemical Pathways Across Complexity and ScaleAlice Abbondanza, Nawon Kim, Ricardo A S Lima-Filho, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Vaccine|July 8, 2022
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021David W McCormick, Stacey L Konkle, Reed Magleby, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Nature Aging|April 16, 2026
p21<sup>+</sup>TREM2<sup>+</sup> senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver diseaseIvan A Salladay-Perez, Itzetl Avila, Lizeth Estrada, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Research Square|November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Pageof 97

Showing results (881-890 of 968) with videos related to

Sort By:
Pageof 97
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Journal of Neurochemistry|July 22, 2025
Dissection of Neurochemical Pathways Across Complexity and ScaleAlice Abbondanza, Nawon Kim, Ricardo A S Lima-Filho, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Vaccine|July 8, 2022
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021David W McCormick, Stacey L Konkle, Reed Magleby, et al.
Ebiomedicine|April 26, 2023
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adultsConstanza Méndez, Hernán F Peñaloza, Bárbara M Schultz, et al.
Mbio|August 10, 2022
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of ConcernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Nature Aging|April 16, 2026
p21<sup>+</sup>TREM2<sup>+</sup> senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver diseaseIvan A Salladay-Perez, Itzetl Avila, Lizeth Estrada, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Research Square|November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Pageof 97